Publications dans lesquelles il/elle collabore avec Sonia Gaztambide Saenz (28)

2024

  1. Association between exposure to air pollution and blood lipids in the general population of Spain

    European Journal of Clinical Investigation, Vol. 54, Núm. 2

2021

  1. Fatty liver index as a predictor for type 2 diabetes in subjects with normoglycemia in a nationwide cohort study

    Scientific Reports, Vol. 11, Núm. 1

  2. Iodine Deficiency and Mortality in Spanish Adults: Di@bet.es Study

    Thyroid, Vol. 31, Núm. 1, pp. 106-114

  3. Thyroid hormone resistance index and mortality in euthyroid subjects: Di@bet.es study

    European journal of endocrinology, Vol. 186, Núm. 1, pp. 95-103

2020

  1. Incidence and regression of metabolic syndrome in a representative sample of the Spanish population: Results of the cohort di@bet.es study

    BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1

  2. Incidence of diabetes mellitus in Spain as results of the nation-wide cohort di@bet.es study

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Ambient temperature and prevalence of diabetes and insulin resistance in the Spanish population: Di@bet.es study

    European Journal of Endocrinology, Vol. 180, Núm. 5, pp. 275-282

  2. Dairy product consumption and metabolic diseases in the Di@bet.es study

    Nutrients, Vol. 11, Núm. 2

2018

  1. Iron deficiency is associated with Hypothyroxinemia and Hypotriiodothyroninemia in the Spanish general adult population: Di@bet.es study

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Population-Based National Prevalence of Thyroid Dysfunction in Spain and Associated Factors: Study

    Thyroid, Vol. 27, Núm. 2, pp. 156-166

  2. Reference values for TSH may be inadequate to define hypothyroidism in persons with morbid obesity: Di@bet.es study

    Obesity, Vol. 25, Núm. 4, pp. 788-793

2016

  1. Low physical activity and its association with diabetes and other cardiovascular risk factors: A nationwide, population-based study

    PLoS ONE, Vol. 11, Núm. 8

  2. Prevalencia, diagnóstico, tratamiento y control de la hipertensión arterial en España. Resultados del estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 69, Núm. 6, pp. 572-578

2015

  1. Estimating cardiovascular risk in Spain by the European guidelines on cardiovascular disease prevention in clinical practice

    Revista Espanola de Cardiologia, Vol. 68, Núm. 5, pp. 417-425

  2. Rationale, design, and baseline characteristics in Evaluation of LIXisenatide in Acute Coronary Syndrome, a long-term cardiovascular end point trial of lixisenatide versus placebo

    American Heart Journal, Vol. 169, Núm. 5, pp. 631-638.e7

2014

  1. Ambient temperature and prevalence of obesity in the spanish population: The di@bet.es study

    Obesity, Vol. 22, Núm. 11, pp. 2328-2332

  2. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clínica e investigación en arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  3. Prevalence of plasma lipid abnormalities and its association with glucose metabolism in Spain: The di@bet.es study

    Clinica e Investigacion en Arteriosclerosis, Vol. 26, Núm. 3, pp. 107-114

  4. Variable patterns of obesity and cardiometabolic phenotypes and their association with lifestyle factors in the Di@bet.es study

    Nutrition, Metabolism and Cardiovascular Diseases, Vol. 24, Núm. 9, pp. 947-955

2013

  1. Consumo de fármacos relacionados con el tratamiento de la diabetes mellitus y otros factores de riesgo cardiovascular en la población española. Estudio Di@bet.es

    Revista Espanola de Cardiologia, Vol. 66, Núm. 11, pp. 854-863